Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Financial Leverage Ratio

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Financial-Leverage-Ratio" stands at 2.04 as of 09/30/2025, the lowest value at least since 06/30/2022, the period currently displayed.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Financial Leverage Ratio" stands at 2.04. This represents a decrease of -0.92 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.53 percent compared to the value the year prior.
The 1 year change in percent is -2.53.
The 3 year change in percent is -10.05.

The Serie's long term average value is 2.16. It's latest available value, on 09/30/2025, is 5.47 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2025, to it's latest available value, on 09/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -13.86%.

Financial Leverage Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Financial Leverage Ratio905,699,262,464.00
LogoJohnson & Johnson - Financial Leverage Ratio486,508,953,600.00
LogoAbbVie Inc - Financial Leverage Ratio399,570,305,024.00
LogoRoche Holding AG - Financial Leverage Ratio317,433,206,677.55
LogoAstraZeneca PLC - Financial Leverage Ratio280,205,508,085.11